These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15548785)

  • 21. HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention.
    Bruhn CA; Gilbert MT
    Lancet Infect Dis; 2011 Apr; 11(4):260-1. PubMed ID: 21453865
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of FDA licensed HIV assays using plasma from Cameroonian blood donors.
    Lee S; Hu J; Tang S; Wood O; Francis K; Machuca A; Rios M; Daniel S; Vockley C; Awazi B; Zekeng L; Hewlett I
    J Med Virol; 2006; 78 Suppl 1():S22-3. PubMed ID: 16622873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi.
    Weber B; Orazi B; Raineri A; Thorstensson R; Bürgisser P; Mühlbacher A; Areal C; Eiras A; Villaescusa R; Camacho R; Diogo I; Roth HJ; Zahn I; Bartel J; Bossi V; Piro F; Atamasirikul K; Permpikul P; Webber L; Singh S
    Clin Lab; 2006; 52(9-10):463-73. PubMed ID: 17078473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Residual risk of HIV-1 transmission: the case of a seroconverter.
    Miceli M; Giuliani M; Gallo A; Mercurio G; Crescimbeni E; Iudicone P
    Clin Lab; 2002; 48(5-6):283-6. PubMed ID: 12071578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors].
    Mutlu B; Meriç M; Willke A
    Mikrobiyol Bul; 2004 Oct; 38(4):445-8. PubMed ID: 15700672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of HIV transmission by screened blood.
    Kinloch S; Perrin L; Hirschel B
    N Engl J Med; 1996 Apr; 334(15):992; author reply 993. PubMed ID: 8596611
    [No Abstract]   [Full Text] [Related]  

  • 27. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of HIV-1 infection in blood donors during the immunological window period using the nucleic acid-amplification technology.
    Scuracchio PS; Poli MC; Lemos MM; Oliveira Filho AG; Salles NA; Chamone DA; Magri M; Cavalcante NJ; Collela R
    Transfus Med; 2007 Jun; 17(3):200-4. PubMed ID: 17561863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HCV and HIV-1 donor screening using nucleic acid amplification technique (NAT).
    O'Riordan J; Williams P; Donnellan J
    Vox Sang; 2005 Nov; 89(4):266. PubMed ID: 16262763
    [No Abstract]   [Full Text] [Related]  

  • 30. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New HIV algorithm holds promise.
    Appold K
    MLO Med Lab Obs; 2012 Apr; 44(4):28, 30. PubMed ID: 22586852
    [No Abstract]   [Full Text] [Related]  

  • 33. First nucleic acid test approved to detect divergent HIV types.
    AIDS Patient Care STDS; 2009 Apr; 23(4):311. PubMed ID: 19367695
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV-1 superinfection in an HIV-2-infected woman with subsequent control of HIV-1 plasma viremia.
    Günthard HF; Huber M; Kuster H; Shah C; Schüpbach J; Trkola A; Böni J
    Clin Infect Dis; 2009 Jun; 48(11):e117-20. PubMed ID: 19382874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in the testing of non-heart-beating cadavers for viral markers: implications for the safety of tissue donors.
    Padley D; Ferguson M; Warwick RM; Womack C; Lucas SB; Saldanha J
    Cell Tissue Bank; 2005; 6(3):171-9. PubMed ID: 16151957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDA approves Procleix HIV-1/HCV assay.
    Am Fam Physician; 2002 Apr; 65(8):1693-4. PubMed ID: 11989643
    [No Abstract]   [Full Text] [Related]  

  • 38. [Establishment of the reference panel for HIV RNA].
    Zhang CT; Song AJ; Li XH; Li J; Wang YC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):321-4. PubMed ID: 15650779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid HIV test kits.
    Health Devices; 2006 May; 35(5):157-77. PubMed ID: 16749249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of HIV antigen and cDNA among antibody-negative blood samples in Nigeria.
    Odaibo GN; Taiwo A; Aken'Ova YA; Olaleye DO
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):284-7. PubMed ID: 18243259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.